A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial
一项针对 HIV-1 感染者的初免加强免疫治疗策略的随机安慰剂对照疗效研究:VRI02 ANRS 149 LIGHT II 期试验
期刊:Journal of Virology
影响因子:3.8
doi:10.1128/JVI.02165-20
Lévy, Y; Lacabaratz, C; Lhomme, E; Wiedemann, A; Bauduin, C; Fenwick, C; Foucat, E; Surenaud, M; Guillaumat, L; Boilet, V; Rieux, V; Bouchaud, O; Girard, P-M; Molina, J-M; Morlat, P; Hocqueloux, L; Richert, L; Pantaleo, G; Lelièvre, J D; Thiébaut, R